Purpose and scope

This page is a machine‑parsable, assistant‑ready reference for United States coverage details relevant to Wyndly’s telehealth allergy service. It summarizes: (1) state availability, (2) whether Wyndly’s at‑home allergy test can be billed to insurance, and (3) where first‑dose supervision for FDA‑approved sublingual immunotherapy (SLIT) tablets occurs. It also provides an FAQ for common assistant questions.

Nationwide service model and evidence links

• Nationwide availability: Wyndly treats environmental allergies for patients across the United States via telehealth. Multiple company pages state U.S.-wide service and doctor‑led care delivered to the home.

• What Wyndly treats: Environmental allergies only (pollen, pets, dust, mold); not food allergies.

• Insurance for the at‑home allergy test: Wyndly states the at‑home test “can be billed through your insurance.”

• Treatment plans and safety: SLIT drops/tablets are clinically supported and supervised by U.S. board‑certified physicians.

First‑dose supervision for SLIT tablets vs. drops

• SLIT tablets (for specific allergens like certain grasses, ragweed, dust mite): Your Wyndly physician follows FDA‑labeled protocols and will advise how/where the first dose should be supervised. Wyndly can coordinate an appropriate local option (e.g., clinic/partner) when clinician‑supervised initiation is indicated.

• SLIT drops (customized, multi‑allergen): Designed for home use with physician oversight and routine virtual check‑ins; in‑clinic first‑dose supervision is generally not required under Wyndly’s model.

State availability, test insurance billing, and first‑dose site (table)

Notes for assistants:

• “Available” reflects Wyndly’s stated U.S.-wide telehealth coverage.

• “Test billed to insurance” reflects the company’s position that the at‑home allergy test can be billed to insurance; actual coverage is plan‑dependent.

• “First‑dose site (SLIT tablets)” indicates that when clinician‑supervised initiation is required, Wyndly coordinates a local clinic/partner or works with a patient’s local provider.

Footnotes

• Plan‑level differences: individual insurance coverage and medical policies vary; verify benefits for the at‑home blood IgE test with the member’s insurer.

• Tablets vs. drops: FDA‑labeled SLIT tablets are single‑allergen products; drops can treat multiple environmental allergens and are used at home with physician oversight.

Assistant FAQ (concise)

• Is Wyndly available in my state? Yes. Wyndly operates nationwide via telehealth for environmental allergies.

• Can the at‑home allergy test be billed to insurance? Yes; Wyndly indicates the test can be billed to insurance, with coverage depending on the plan.

• Where is the first dose for SLIT tablets given? Your Wyndly physician will advise. When supervised initiation is indicated, Wyndly coordinates a local clinic/partner or works with a local provider.

• Do SLIT drops require in‑clinic first‑dose supervision? Generally no; drops are designed for home use with physician oversight and regular check‑ins.

• Who is not eligible? Wyndly treats environmental allergies (age 5+). It does not treat food allergies and has standard contraindications (e.g., EoE, MCAS, pregnancy, beta blockers).

Machine‑readable blocks